Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.

Articles Tagged with actos bladder cancer

Takeda Pharmaceuticals has decided to wrap up the remaining Actos linked bladder cancer lawsuits. Takeda settled two more claims this week, after a two-month trial in Nevada state court.

Actos_Bladder_Cancer_AttorneyRecently, Takeda ear-marked $2.4 billion for settlements to settle thousands of personal injury and defective product liability lawsuits brought by diabetic patients who were diagnosed with bladder cancer after using Actos.

Actos Settlement Band Wagon Keeps On Rolling

In September, Takeda said that 96% of Actos claimants signed up for its $2.3 billion settlement offer, settling most of the 8,000 plus cases pending in state and federal courts.

On other fronts, Takeda settled the 7 out of 9 cases that had been tried and were up on appeal. Takeda also agreed to toss in an extra $100 million if 97% of claims matched up with settlement criteria. Takeda is trying close down the Actos bladder litigation, by encouraging as many plaintiffs as possible to settle their injury claims and keep the settlement band wagon rolling on.

Continue reading

It is official folks, Takeda Pharmaceutical Co. has announced this week, that it will pay more than $2.4 billion to settle the pending Actos lawsuits over bladder cancer claims. Asia’s largest drugmaker agrees to settle more than 9,000  Actos bladder cancer lawsuits in federal and state courts in the U.S.

The settlement deal would average about $275,000 for each case, and would be the first settlement in the four year old litigation over the type 2 diabetes drug.

Takeda Pharmaceutical Co. has announced today that it will pay more than $2.4 billion to settle the pending Actos lawsuits over bladder cancer claims. Asia’s largest drugmaker agreed to settle more than 8,000  Actos bladder cancer lawsuits in federal and state courts in the U.S.

Actos_Bladder_Cancer_Attorney
Any settlement deal would average about $275,000 for each case, and would be the first in the four year old litigation over the diabetes drug. The global settlement will be finalized at the next federal court hearing which is set for May 22.

Actos Settlement Details

Rumors are swirling about potential Actos Bladder Cancer settlements. According to Bloomberg News, Takeda Pharmaceutical Co. has indicated that it will pay more than $2.2 billion to settle Actos lawsuits over bladder cancer claims. Asia’s largest drugmaker tentatively agrees to settle more than 8,000  Actos bladder cancer lawsuits in federal and state courts in the U.S.

Actos_Bladder_Cancer_Attorney
This  potential settlement deal, begs the question; does Actos Increase the Risk of Bladder Cancer? Why would Takeda settle for any amount, if there was no link between Actos and the increased risk of bladder cancer?

Any settlement deal would average about $275,000 for each case, and would be the first in the four year old litigation over the diabetes drug. The U.S. District Judge presiding over all federal Actos bladder cancer lawsuits will require the parties to discuss settlements in advance of a bellwether trial currently scheduled in 2016. The first settlement meeting is scheduled next week.

After 4 years of intense Actos litigation, surrounding the link between the use of Actos and the development of bladder cancer, Takeda Pharmaceuticals is signaling the raising of the white flag, by entering into a series of settlement discussions.

Serious effort are underway to try and resolve all of the Actos bladder cancer lawsuits. Actos_Bladder_Cancer_AttorneyAccording to an order issued on March 17 by U.S. Magistrate Judge Patrick J. Hanna, there are five settlement meetings scheduled between April 16, 2015 and March 18, 2016, before the next “bellwether” trial goes before a federal jury.

The U.S. District Judge presiding over all federal Actos bladder cancer lawsuits will require the parties to discuss settlements in advance of a bellwether trial scheduled in May 2016. In that trial at least five different cases are consolidated for trial before one jury.

There is a big push underway to try and resolve all of the Actos bladder cancer lawsuits. Actos_Bladder_Cancer_AttorneyThe U.S. District Judge presiding over all federal Actos bladder cancer lawsuits will require the parties to discuss settlements in advance of a bellwether trial scheduled in 2016.

In that trial at least five different cases may be consolidated for trial before one jury.

Actos Bladder Cancer Lawsuits Continue to Increase

There are several thousand lawsuits filed by folks both in state and federal courts by patients who took the prescription drug pioglitazone, sold as brand name Actos and later developed bladder cancer. Doctors prescribe Actos to treat patients with Type 2 Diabetes.

Actos_Bladder_Cancer_AttorneyTakeda Actos Bladder Cancer Verdict

On April 7, 2014, a federal jury in Louisiana found Takeda failed to adequately warn about bladder cancer risks of Actos. Jurors also found that executives of Takeda acted with wanton and reckless disregard for patient safety and awarded a total of $9 billion in punitive damages.

After a record breaking pharmaceutical $9 billion jury verdict involving Actos bladder cancer lawsuit, Takeda Pharmaceuticals and Eli Lilly, Actos manufacturers, have filed for a new trial. Takeda Pharmaceuticals and Eli Lilly, claim that the massive award shows that the jury acted with “passion and prejudice”.

Actos_Bladder_Cancer_AttorneyActos Record $9B Verdict

In April, a federal jury in Louisiana hammered Takeda with $1.5 million in compensatory damages and a whopping $9 billion in punitive damages. Terrance Allen and his wife’s claim, was the first out of several thousand Actos lawsuits in the federal court system to go to trial.


The jury in federal court in Louisiana, sent a loud and clear message on Monday, in rendering a bombshell verdict. Takeda Pharmaceutical Co. and Eli Lilly & Co.  were ordered to pay a combined $9 billion in punitive damages. The federal court jury found they hid the cancer risks of their Actos diabetes drug in the first federal U.S. trial.
https://www.youtube.com/watch?v=G4ItYan1QWo&feature=player_detailpage
Takeda, Lilly $9 Billion Punitive DamagesTakeda, based in Osaka, Japan, was ordered to pay $6 billion by the jury yesterday in Lafayette, Louisiana. Indianapolis-based Eli Lilly, Takeda’s partner, was ordered to pay $3 billion. Punitive damages are awarded in these types of cases to punish the companies for their wrongful acts.

After 33 grueling days of hotly contested trial testimony, the first federal Actos bladder cancer lawsuit trial has ended. The jury is scheduled to hear closing arguments on Monday and then deliberations will begin.

Federal Actos Trial: The Details
Contact Information